Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New digital app aims to curb cocaine and meth use

NCT ID NCT07221396

ENROLLING_BY_INVITATION Disease control Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 37 times

Summary

This pilot study tests a web-based program called LDART for adults with stimulant use disorder (cocaine or methamphetamine). The program includes daily goal setting, motivational messages from people in recovery, and links to support groups. Researchers want to see if it's feasible and acceptable, and whether it helps reduce stimulant use. The study enrolls 80 adults in Connecticut who use stimulants frequently and want to cut down.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE USE DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Yale University

    New Haven, Connecticut, 06520, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

LDART (web-based digital intervention with goal setting, motivational messages, and recovery group information)

What this could lead to

If it works, this could provide a low-cost, accessible digital tool to help people reduce or stop stimulant use.

What could go wrong

This is a small pilot study with only 80 participants in one state, so results may not apply broadly. The intervention is still being tested for feasibility and may not lead to lasting behavior change.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.